Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
Alina Wilkowska, Adam Włodarczyk, Maria Gałuszko-Węgielnik, Mariusz S Wiglusz, Wiesław J Cubała Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, PolandCorrespondence: Alina WilkowskaDepart...
Guardado en:
Autores principales: | Wilkowska A, Włodarczyk A, Gałuszko-Węgielnik M, Wiglusz MS, Cubała WJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e94bf42b6ac447aa18b576d846631ed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
por: Szarmach J, et al.
Publicado: (2020) -
Ketamine in Bipolar Disorder: A Review
por: Wilkowska A, et al.
Publicado: (2020) -
Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Maria Gałuszko-Wȩgielnik, et al.
Publicado: (2021) -
Clozapine As Transformative Treatment In Bipolar Patients
por: Wilkowska A, et al.
Publicado: (2019) -
Mania following ketamine abuse
por: Lu YY, et al.
Publicado: (2016)